Trial · NCT04540094
Adverse events44
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 44
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Blood and Lymphatic | Blood and lymphatic system disorders | 5% Human Albumin Solution | 3 | 150 | 3 |
| other | Blood and Lymphatic | Blood and lymphatic system disorders | Intravenous Balanced Crystalloid | 1 | 150 | 1 |
| other | Cardiac Disorders | Cardiac disorders | 5% Human Albumin Solution | 2 | 150 | 2 |
| other | Cardiac Disorders | Cardiac disorders | Intravenous Balanced Crystalloid | 1 | 150 | 1 |
| other | Gastrointestinal disorders | Gastrointestinal disorders | 5% Human Albumin Solution | 3 | 150 | 3 |
| other | Gastrointestinal disorders | Gastrointestinal disorders | Intravenous Balanced Crystalloid | 0 | 150 | 0 |
| other | General disorders and administration | General disorders | 5% Human Albumin Solution | 2 | 150 | 2 |
| other | General disorders and administration | General disorders | Intravenous Balanced Crystalloid | 2 | 150 | 2 |
| other | Infections and infestations | Infections and infestations | 5% Human Albumin Solution | 0 | 150 | 0 |
| other | Infections and infestations | Infections and infestations | Intravenous Balanced Crystalloid | 2 | 150 | 2 |
| other | Investigations | Investigations | 5% Human Albumin Solution | 2 | 150 | 2 |
| other | Investigations | Investigations | Intravenous Balanced Crystalloid | 5 | 150 | 6 |
| other | Metabolism and nutrition disorders | Metabolism and nutrition disorders | 5% Human Albumin Solution | 4 | 150 | 7 |
| other | Metabolism and nutrition disorders | Metabolism and nutrition disorders | Intravenous Balanced Crystalloid | 0 | 150 | 0 |
| other | Musculoskeletal and connective tissue disorders | Musculoskeletal and connective tissue disorders | 5% Human Albumin Solution | 0 | 150 | 0 |
| other | Musculoskeletal and connective tissue disorders | Musculoskeletal and connective tissue disorders | Intravenous Balanced Crystalloid | 1 | 150 | 1 |
| other | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | 5% Human Albumin Solution | 2 | 150 | 2 |
| other | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Intravenous Balanced Crystalloid | 0 | 150 | 0 |
| other | Nervous system disorders | Nervous system disorders | 5% Human Albumin Solution | 1 | 150 | 1 |
| other | Nervous system disorders | Nervous system disorders | Intravenous Balanced Crystalloid | 0 | 150 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04540094/events